{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:57:28Z","timestamp":1787990248902,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejim.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T09:46:48Z","timestamp":1542102408000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study"],"prefix":"10.1016","volume":"61","author":[{"given":"B\u00fclent","family":"\u00d6zlek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"\u00d6zlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicaz Zencirk\u0131ran","family":"A\u011fu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Tekinalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"\u00c7il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7841-0227","authenticated-orcid":false,"given":"O\u011fuzhan","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zcan","family":"Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedri Caner","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Renc\u00fczo\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altu\u011f","family":"\u00d6sken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00fctf\u00fc","family":"Bekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ozan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir U\u011fur","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadriye Memi\u00e7","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Sevin\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurbet \u00d6zge","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Biteker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejim.2018.11.001_bb0005","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejim.2018.11.001_bb0010","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ejim.2018.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart failure Association (HFA) of the ESC","volume":"33","author":"JJ","year":"2012","journal-title":"Eur Heart J"},{"issue":"27","key":"10.1016\/j.ejim.2018.11.001_bb0020","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2018.11.001_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2018.11.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018719","article-title":"Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)","volume":"7","author":"Farr\u00e9","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ejim.2018.11.001_bb0035","first-page":"311","article-title":"Rationale, Design, and Methodology of the APOLLON trial: a comPrehensive, ObservationaL registry of heart faiLure with midrange and preserved ejectiON fraction","volume":"19","author":"\u00d6zlek","year":"2018","journal-title":"Anatol J Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2018.11.001_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2018.11.001_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"issue":"10","key":"10.1016\/j.ejim.2018.11.001_bb0050","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.amjcard.2018.01.040","article-title":"Comorbidities, sociodemographic factors, and hospitalizations in outpatients with heart failure and preserved ejection fraction","volume":"121","author":"Georgiopoulou","year":"2018","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.ejim.2018.11.001_bb0055","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2018.11.001_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.ejim.2018.11.001_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2018.11.001_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2018.11.001_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ejim.2018.11.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.12283","article-title":"Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis","author":"Lauritsen","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.ejim.2018.11.001_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population","volume":"168","author":"Cheng","year":"2014","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2018.11.001_bb0090","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ejhf.1058","article-title":"What have we learned about heart failure with mid-range ejection fraction one year after its introduction?","volume":"19","author":"Nauta","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ejim.2018.11.001_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"Heart failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.ejim.2018.11.001_bb0100","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ejhf.798","article-title":"Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in elderly patients with Congestive Heart failure (TIME-CHF)","volume":"19","author":"Rickenbacher","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.ejim.2018.11.001_bb0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.ejim.2018.11.001_bb0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12872-016-0418-9","article-title":"Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study","volume":"16","author":"Abebe","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.ejim.2018.11.001_bb0115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.amjcard.2017.12.012","article-title":"Investigators for the WET-NaDEF Collaboration Project. Long-Term Prognostic significance of Plasma B-Type Natriuretic Peptide Level in patients with Acute Heart failure with Reduced, Mid-Range, and Preserved Ejection Fractions","volume":"121","author":"Hamatani","year":"2018","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2018.11.001_bb0120","doi-asserted-by":"crossref","first-page":"e003989","DOI":"10.1161\/JAHA.116.003989","article-title":"Biomarker profiles in heart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ejim.2018.11.001_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ejim.2018.11.001_bb0130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.ejim.2018.11.001_bb0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jchf.2017.06.013","article-title":"Heart failure with Mid-Range (Borderline) Ejection Fraction","volume":"5","author":"Hsu","year":"2017","journal-title":"Clin Impl Future Direct JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.ejim.2018.11.001_bb0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"OPTIMIZE-HF investigators and hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2018.11.001_bb0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.hfc.2014.04.007","article-title":"Current therapeutic approach in heart failure with preserved ejection fraction","volume":"10","author":"Nativi-Nicolau","year":"2014","journal-title":"Heart Fail Clin"},{"issue":"16","key":"10.1016\/j.ejim.2018.11.001_bb0150","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurheartj\/ehu067","article-title":"Heart failure with preserved ejection fraction: a clinical dilemma","volume":"35","author":"Komajda","year":"2014","journal-title":"Eur Heart J"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T21:58:45Z","timestamp":1551304725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518304461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S0953620518304461"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.11.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}